1. Advances in siRNA delivery for breast cancer therapy: from molecular design to therapeutic application
Khan Ms, Abourehab Mas, Gupta G, Goh Kw, Sahebkar A, Kesharwani P
Breast cancer progression is driven by molecular heterogeneity, drug resistance (DR), and interactions within the tumour microenvironment (TME), creating an urgent need for therapies that can selectively suppress disease-associated genes. Small interfering RNA (siRNA) can silence targets involved in tumour growth…
Read the article